Evidence map›Paper›PMID 41188668›Full record

SynthesisDigestive diseases and sciences2026

Role of Prophylactic Endoscopic Gallbladder Stent Placement for Prevention of Acute Cholecystitis in Patients Receiving Stenting for Malignant Biliary Obstruction: A Meta-Analysis.

Zahid Ijaz Tarar, Mustafa Gandhi, Umer Farooq, AhtshamUllah Chaudhry, Gopala K Konduri, Ahmad Zain, Zohaib Ahmed, Baltej Singh, Nirav Thosani

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zahid Ijaz TararDivision of Gastroenterology and Hepatology, School of Medicine, University of Missouri, 1 Hospital Dr, Columbia, MO, 65212, USA. drzahidejaz@hotmail.com.
Mustafa GandhiDivision of Gastroenterology and Hepatology, School of Medicine, University of Missouri, 1 Hospital Dr, Columbia, MO, 65212, USA.
Umer FarooqDivision of Gastroenterology and Hepatology, Saint Louis University, St Louis, USA.
AhtshamUllah ChaudhryDivision of Gastroenterology and Hepatology, University of Kansas, Wichita, USA.
Gopala K KonduriDepartment of Medicine, School of Medicine, University of Missouri, Columbia, USA.
Ahmad ZainDepartment of Medicine, UCHealth Parkview Medical Center, Pueblo, CO, 81003, USA.
Zohaib AhmedDivision of Gastroenterology and Hepatology, University of Toledo, Toledo, OH, USA.
Baltej SinghDepartment of Medicine, Christiana Care Union Hospital, Elkton, Maryland, USA.
Nirav ThosaniCenter for Interventional Gastroenterology at UTHealth (iGUT), McGovern Medical School at UTHealth, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe stent placement in malignant biliary obstruction (MBO) carries the risk acute cholecystitis. We studied if prophylactic endoscopic gallbladder stenting (EGBS) reduces the risk of acute cholecystitis in MBO patients receiving metal stents.

methodsWe searched multiple databases to select studies which compared the risk of acute cholecystitis in MBO patients which received prophylactic EGBS Vs. no-stent group. We studied the odds of acute cholecystitis, acute pancreatitis, acute cholangitis, and overall adverse event rate between prophylactic EGBS Vs. no-stent group. We calculated the pooled odds with 95% CI for categorical variables and standardized mean difference (SMD) with 95% CI for continuous variables.

resultsWe included four studies, consisting of 509 (prophylactic EGBS, n = 87, no-stent, n = 422) patients. The rate of acute cholecystitis in prophylactic EGBS group was 3.0% (95% CI 0.9-9.9, I

conclusionProphylactic EGBS is safe and reduces the risk of acute cholecystitis before placing metal stents in MBO patients.

Indexed as

Cholecystitis, AcuteCholestasisStentsHumansPancreatitisAcute cholecystitisCovered metal stentsMalignant biliary obstructionMeta-analysisProphylactic GB stenting

Identifiers

PMID41188668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.